Home › NDC Lookup › RxCUI directory › RxCUI 859975

Asenapine 10 MG Sublingual Tablet — RxCUI 859975

RxNorm drug concept · Semantic clinical drug
RxCUI 859975 Semantic clinical drug · SCD ● Current RxNorm concept 21 FDA products 40 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI859975
Official nameAsenapine 10 MG Sublingual Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asasenapine (as asenapine maleate) 10 MG Sublingual Tablet
FDA products mapped21
Package NDCs mapped40
Reported Medicaid activity (SDUD)46,014 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Asenapine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This is really important — swallowing the tablet dramatically reduces how much of the medication actually gets into your system. When it dissolves under your tongue, it absorbs dir...
  • Why do I have to let the tablet dissolve under my tongue instead of just swallowing it?
  • Yes, sleepiness and dizziness are among the most commonly reported side effects, especially early on. The dizziness can be worse when you stand up quickly, because asenapine can ca...
  • I feel really sleepy and dizzy since starting this — is that normal?
📖 Read our full Asenapine guide →

🕸️ Concept Web — How Asenapine 10 MG Sublingual Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Asenapine 10 MG Sublingual Tablet RxCUI 859975

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Asenapine 784649
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Saphris 859976
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Asenapine Sublingual Tablet 859974
    • Asenapine Oral Product 1152953
    • Asenapine Pill 1152954
    • Asenapine Sublingual Product 1295345
    • Asenapine Sublingual Tablet [Saphris] 859978
    • Saphris Oral Product 1185991
    • Saphris Pill 1185992
    • Saphris Sublingual Product 1296869
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Asenapine 10 MG SCDC · 859973
  • Asenapine Sublingual Tablet SCDF · 859974
  • Asenapine Oral Product SCDG · 1152953
  • Asenapine Pill SCDG · 1152954
  • Asenapine Sublingual Product SCDG · 1295345

Brand-Name Concepts

  • Asenapine 10 MG Sublingual Tablet [Saphris] SBD · 859979
  • Asenapine 10 MG [Saphris] SBDC · 859977
  • Asenapine Sublingual Tablet [Saphris] SBDF · 859978
  • Saphris Oral Product SBDG · 1185991
  • Saphris Pill SBDG · 1185992
  • Saphris Sublingual Product SBDG · 1296869
  • Saphris BN · 859976

📦 FDA Products & Package NDCs

21 products · 40 package NDCs
40 package NDCs map to RxCUI 859975 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00456-2402-10 1 CASE in 1 CARTON (0456-2402-10) / 1 BLISTER PACK in 1 CAS... SAPHRIS Allergan, Inc. 2014-12-30
00456-2402-60 6 CASE in 1 CARTON (0456-2402-60) / 1 BLISTER PACK in 1 CAS... SAPHRIS Allergan, Inc. 2014-12-30
00456-2402-63 10 BLISTER PACK in 1 CARTON (0456-2402-63) / 10 TABLET in 1... SAPHRIS Allergan, Inc. 2014-12-30
00456-2405-10 1 CASE in 1 CARTON (0456-2405-10) / 1 BLISTER PACK in 1 CAS... SAPHRIS Allergan, Inc. 2013-09-30
00456-2405-60 6 CASE in 1 CARTON (0456-2405-60) / 1 BLISTER PACK in 1 CAS... SAPHRIS Allergan, Inc. 2013-09-30
00456-2410-10 1 CASE in 1 CARTON (0456-2410-10) / 1 BLISTER PACK in 1 CAS... SAPHRIS Allergan, Inc. 2013-09-30
00456-2410-60 6 CASE in 1 CARTON (0456-2410-60) / 1 BLISTER PACK in 1 CAS... SAPHRIS Allergan, Inc. 2013-09-30
42794-0016-08 30 TABLET in 1 BOTTLE, PLASTIC (42794-016-08) ASENAPINE Sigmapharm Laboratories, LLC 2020-12-14
42794-0016-10 60 TABLET in 1 BOTTLE, PLASTIC (42794-016-10) ASENAPINE Sigmapharm Laboratories, LLC 2020-12-14
42794-0016-22 10 TABLET in 1 BOTTLE, PLASTIC (42794-016-22) ASENAPINE Sigmapharm Laboratories, LLC 2020-12-14
42794-0017-08 30 TABLET in 1 BOTTLE, PLASTIC (42794-017-08) ASENAPINE Sigmapharm Laboratories, LLC 2020-12-14
42794-0017-10 60 TABLET in 1 BOTTLE, PLASTIC (42794-017-10) ASENAPINE Sigmapharm Laboratories, LLC 2020-12-14
42794-0017-22 10 TABLET in 1 BOTTLE, PLASTIC (42794-017-22) ASENAPINE Sigmapharm Laboratories, LLC 2020-12-14
46708-0198-31 100 BLISTER PACK in 1 CARTON (46708-198-31) / 10 TABLET in... Asenapine Alembic Pharmaceuticals Limited 2020-12-10
46708-0198-60 60 BLISTER PACK in 1 CARTON (46708-198-60) / 10 TABLET in 1... Asenapine Alembic Pharmaceuticals Limited 2020-12-10
46708-0199-31 100 BLISTER PACK in 1 CARTON (46708-199-31) / 10 TABLET in... Asenapine Alembic Pharmaceuticals Limited 2020-12-10
46708-0199-60 60 BLISTER PACK in 1 CARTON (46708-199-60) / 10 TABLET in 1... Asenapine Alembic Pharmaceuticals Limited 2020-12-10
46708-0544-31 100 BLISTER PACK in 1 CARTON (46708-544-31) / 10 TABLET in... Asenapine Alembic Pharmaceuticals Limited 2021-07-20
46708-0544-60 60 BLISTER PACK in 1 CARTON (46708-544-60) / 10 TABLET in 1... Asenapine Alembic Pharmaceuticals Limited 2021-07-20
51991-0358-11 10 BLISTER PACK in 1 BOX (51991-358-11) / 10 TABLET in 1 BL... Asenapine Breckenridge Pharmaceutical, Inc. 2021-03-08
51991-0358-60 6 BLISTER PACK in 1 BOX (51991-358-60) / 10 TABLET in 1 BLI... Asenapine Breckenridge Pharmaceutical, Inc. 2021-03-08
51991-0359-11 10 BLISTER PACK in 1 BOX (51991-359-11) / 10 TABLET in 1 BL... Asenapine Breckenridge Pharmaceutical, Inc. 2021-03-08
51991-0359-60 6 BLISTER PACK in 1 BOX (51991-359-60) / 10 TABLET in 1 BLI... Asenapine Breckenridge Pharmaceutical, Inc. 2021-03-08
51991-0360-11 10 BLISTER PACK in 1 BOX (51991-360-11) / 10 TABLET in 1 BL... Asenapine Breckenridge Pharmaceutical, Inc. 2020-12-10
51991-0360-60 6 BLISTER PACK in 1 BOX (51991-360-60) / 10 TABLET in 1 BLI... Asenapine Breckenridge Pharmaceutical, Inc. 2020-12-10
51991-0361-11 10 BLISTER PACK in 1 BOX (51991-361-11) / 10 TABLET in 1 BL... Asenapine Breckenridge Pharmaceutical, Inc. 2020-12-10
51991-0361-60 6 BLISTER PACK in 1 BOX (51991-361-60) / 10 TABLET in 1 BLI... Asenapine Breckenridge Pharmaceutical, Inc. 2020-12-10
51991-0928-11 10 BLISTER PACK in 1 BOX (51991-928-11) / 10 TABLET in 1 BL... Asenapine Breckenridge Pharmaceutical, Inc. 2020-12-10
51991-0928-60 6 BLISTER PACK in 1 BOX (51991-928-60) / 10 TABLET in 1 BLI... Asenapine Breckenridge Pharmaceutical, Inc. 2020-12-10
62332-0198-31 100 BLISTER PACK in 1 CARTON (62332-198-31) / 10 TABLET in... Asenapine Alembic Pharmaceuticals Inc. 2020-12-10
62332-0198-60 60 BLISTER PACK in 1 CARTON (62332-198-60) / 10 TABLET in 1... Asenapine Alembic Pharmaceuticals Inc. 2020-12-10
62332-0199-31 100 BLISTER PACK in 1 CARTON (62332-199-31) / 10 TABLET in... Asenapine Alembic Pharmaceuticals Inc. 2020-12-10
62332-0199-60 60 BLISTER PACK in 1 CARTON (62332-199-60) / 10 TABLET in 1... Asenapine Alembic Pharmaceuticals Inc. 2020-12-10
62332-0544-31 100 BLISTER PACK in 1 CARTON (62332-544-31) / 10 TABLET in... Asenapine Alembic Pharmaceuticals Inc. 2021-07-20
62332-0544-60 60 BLISTER PACK in 1 CARTON (62332-544-60) / 10 TABLET in 1... Asenapine Alembic Pharmaceuticals Inc. 2021-07-20
69539-0057-34 60 TABLET in 1 BOX (69539-057-34) Asenapine MSN LABORATORIES PRIVATE LIMITED 2021-08-27
69539-0058-34 60 TABLET in 1 BOX (69539-058-34) Asenapine MSN LABORATORIES PRIVATE LIMITED 2021-08-27
69539-0059-34 60 TABLET in 1 BOX (69539-059-34) Asenapine MSN LABORATORIES PRIVATE LIMITED 2021-08-27
69539-0060-34 60 TABLET in 1 BOX (69539-060-34) Asenapine MSN LABORATORIES PRIVATE LIMITED 2021-08-27
69539-0245-34 60 TABLET in 1 BOX (69539-245-34) Asenapine MSN LABORATORIES PRIVATE LIMITED 2021-08-27
Observed labelers: Breckenridge Pharmaceutical, Inc. (10) · Allergan, Inc. (7) · Alembic Pharmaceuticals Inc. (6) · Alembic Pharmaceuticals Limited (6) · Sigmapharm Laboratories, LLC (6) · MSN LABORATORIES PRIVATE LIMITED (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.